APA (7th ed.) Citation

Zafeiropoulou, K., Kalampounias, G., Alexis, S., Androutsopoulou, T., Katsoris, P., & Symeonidis, A. (2023). Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels. Curēus (Palo Alto, CA), 15(12), e49843. https://doi.org/10.7759/cureus.49843

Chicago Style (17th ed.) Citation

Zafeiropoulou, Kalliopi, Georgios Kalampounias, Spyridon Alexis, Theodosia Androutsopoulou, Panagiotis Katsoris, and Argiris Symeonidis. "Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels." Curēus (Palo Alto, CA) 15, no. 12 (2023): e49843. https://doi.org/10.7759/cureus.49843.

MLA (9th ed.) Citation

Zafeiropoulou, Kalliopi, et al. "Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels." Curēus (Palo Alto, CA), vol. 15, no. 12, 2023, p. e49843, https://doi.org/10.7759/cureus.49843.